HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robin Foà Selected Research

Sialic Acid Binding Ig-like Lectin 3

10/2011High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation.
3/2007Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robin Foà Research Topics

Disease

57B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 11/2005
53Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 08/2002
30Neoplasms (Cancer)
01/2021 - 10/2002
29BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2022 - 12/2009
20Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2020 - 10/2002
18Leukemia
01/2019 - 10/2002
15Philadelphia Chromosome
01/2022 - 03/2006
14Infections
01/2022 - 09/2005
14Residual Neoplasm
01/2021 - 02/2006
13Hematologic Neoplasms (Hematological Malignancy)
10/2021 - 12/2005
10Multiple Myeloma
01/2016 - 08/2006
9Disease Progression
12/2021 - 11/2007
8Lymphoma (Lymphomas)
01/2018 - 12/2005
7Acute Promyelocytic Leukemia
01/2019 - 04/2006
6COVID-19
01/2022 - 01/2020
6Primary Myelofibrosis (Myelosclerosis)
08/2021 - 07/2010
6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2013 - 03/2003
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 01/2017
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020 - 05/2007
4Thrombosis (Thrombus)
09/2020 - 10/2007
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2020 - 07/2004
4Neutropenia
11/2017 - 09/2005
3Exanthema (Rash)
01/2022 - 10/2015
3Febrile Neutropenia
10/2021 - 05/2014
3Agammaglobulinemia (Hypogammaglobulinemia)
07/2021 - 12/2015
3Hairy Cell Leukemia
01/2021 - 01/2012
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2020 - 10/2017
3Splenomegaly
10/2020 - 03/2014
3Venous Thromboembolism
01/2020 - 11/2007
3Anemia
01/2019 - 08/2006
3Thrombocytopenia (Thrombopenia)
11/2017 - 11/2007
3Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
11/2016 - 01/2009
3Pathologic Complete Response
07/2010 - 06/2005
2Tumor Lysis Syndrome
01/2021 - 11/2018
2Polycythemia Vera
10/2020 - 10/2008
2Sepsis (Septicemia)
09/2020 - 11/2015
2Hypertension (High Blood Pressure)
07/2020 - 01/2019
2Blast Crisis (Blast Phase)
01/2020 - 01/2010

Drug/Important Bio-Agent (IBA)

26Biological ProductsIBA
01/2020 - 11/2005
25Tyrosine Kinase InhibitorsIBA
01/2022 - 11/2008
21Rituximab (Mabthera)FDA Link
12/2021 - 08/2007
15Imatinib Mesylate (Gleevec)FDA Link
01/2021 - 05/2007
14ibrutinibIBA
01/2022 - 11/2016
10fludarabineIBA
11/2020 - 12/2011
10Pharmaceutical PreparationsIBA
10/2020 - 04/2009
9Phosphotransferases (Kinase)IBA
01/2021 - 04/2011
9Bendamustine HydrochlorideFDA Link
01/2021 - 10/2015
8Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2020 - 11/2008
7Dasatinib (BMS 354825)FDA Link
12/2021 - 01/2010
7DNA (Deoxyribonucleic Acid)IBA
01/2017 - 12/2008
6nilotinibFDA Link
10/2022 - 01/2019
6ponatinibIBA
01/2022 - 09/2018
6ruxolitinibIBA
08/2021 - 04/2019
6Proteins (Proteins, Gene)FDA Link
10/2015 - 10/2002
5Immunoglobulins (Immunoglobulin)IBA
12/2020 - 11/2006
5Lenalidomide (CC 5013)FDA Link
11/2017 - 10/2007
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2016 - 11/2007
5RNA (Ribonucleic Acid)IBA
01/2016 - 03/2007
4Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2010
4blinatumomabIBA
12/2021 - 01/2017
4Anti-Bacterial Agents (Antibiotics)IBA
10/2021 - 05/2014
4CytokinesIBA
10/2020 - 12/2005
4Messenger RNA (mRNA)IBA
01/2020 - 04/2008
4Clofarabine (Clolar)FDA Link
12/2019 - 10/2009
4AnticoagulantsIBA
01/2019 - 03/2014
4Histamine (Histamine Dihydrochloride)FDA Link
01/2018 - 12/2015
4Interleukin-2 (IL2)IBA
01/2018 - 12/2015
4MicroRNAs (MicroRNA)IBA
04/2015 - 06/2007
4LigandsIBA
07/2014 - 10/2007
4Protein Isoforms (Isoforms)IBA
12/2008 - 03/2003
3SteroidsIBA
01/2022 - 05/2007
3Oxygen (Dioxygen)IBA
12/2021 - 07/2008
3idelalisibIBA
08/2021 - 01/2019
3Azacitidine (5 Azacytidine)FDA Link
10/2020 - 08/2019
3obinutuzumabIBA
01/2020 - 01/2018
3Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2020 - 01/2015
3Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2019 - 04/2006
3Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2018 - 10/2012
3purineIBA
11/2017 - 01/2012
3Alemtuzumab (Campath)FDA Link
11/2017 - 02/2012
3Monoclonal AntibodiesIBA
10/2017 - 12/2005
3AntigensIBA
02/2016 - 03/2007
3Prednisone (Sone)FDA LinkGeneric
03/2013 - 10/2007
3Bortezomib (Velcade)FDA Link
03/2013 - 10/2007
3Transcription Factors (Transcription Factor)IBA
01/2013 - 10/2002
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2012 - 03/2007
3OligonucleotidesIBA
07/2010 - 01/2006
2LDL Lipoproteins (beta Lipoproteins)IBA
08/2021 - 01/2020
2VemurafenibIBA
01/2021 - 10/2015
2Agammaglobulinaemia Tyrosine KinaseIBA
01/2021 - 10/2018

Therapy/Procedure

49Therapeutics
01/2022 - 10/2005
25Drug Therapy (Chemotherapy)
01/2022 - 09/2005
7Immunotherapy
01/2018 - 12/2015
5Salvage Therapy
01/2020 - 01/2012
4Hematopoietic Stem Cell Transplantation
01/2021 - 08/2012
4Radiotherapy
01/2020 - 05/2007
4Stem Cell Transplantation
01/2018 - 10/2005
3Homologous Transplantation
01/2022 - 01/2010
3Aftercare (After-Treatment)
10/2015 - 04/2009
2Catheters
09/2020 - 11/2015